News

Always up to date

Groundbreaking research into nuclear medicine? The contribution of nuclear energy to climate goals? We make a concrete contribution to a cleaner, healthier world.

Follow the current developments regarding our nuclear research, our advice, and the production of life-saving nuclear medicines here.

Want to stay informed of all nuclear developments regarding health and energy? Sign up for our updates at the bottom of this page.

Contact for the media

Spokesperson coordinates all incoming media inquiries. If you have a question, please contact:

Cora Blankendaal
Press officer

Latest news

31 March 2022

Minister of Health, Welfare and Sport Ernst Kuipers visited the Energy & Health Campus in Petten on 30 March. The minister spoke with medical experts and the management of NRG | PALLAS about the importance of medical isotope production, research and about the PALLAS-project. Special attention was paid to the development of new therapeutic isotopes and the collaboration with university medical centers.

17 March 2022

Over 1.1 million patient doses will be produced over the next month, which will be used to diagnose and treat life-threatening diseases such as cancer and cardiovascular diseases.

03 March 2022

The HFR did not start up on 20 January 2022 due to a leak in a water system. This is a system that supplies water to test facilities, which are located on the outside of the reactor core. The leak was located in the reactor hall, within the so-called containment. There was no risk to nuclear safety, man or the environment.

01 March 2022

Environmental Service Noord-Holland Noord has granted a permit for the construction of the PALLAS-reactor and for the realization of the Nuclear Health Centre (NHC) under the Nature Conservation Act. The granting of the permit means that PALLAS can continue with the realization of the building plans on the Energy & Health Campus in Petten. Marco Visser, licensing manager PALLAS: ‘This is a wonderful step forward. Our approach, project specific ecological research, has shown that nitrogen deposition does not stand in the way of the realisation of the PALLAS-reactor and our production facility at the NHC.’

17 February 2022

Sietsche Eppinga will take up the position of Construction Director PALLAS-reactor as of March 1, 2022. Sietsche will lead the construction work for the PALLAS-reactor on the Energy and Health Campus in Petten.

14 February 2022

VVD Member of Parliament Silvio Erkens and CU Member of Parliament Pieter Grinwis, both spokespersons for Climate and Energy for their parties, visited the Energy & Health Campus in Petten on 11 February. This afternoon Erkens and Grinwis discussed the development of new nuclear knowledge infrastructure for energy and health applications with board members and program managers of NRG|PALLAS.

23 December 2021

Eric Cervi received the award of best 2021 Ph.D. thesis in the field of fluid-dynamics by the Italian Union of Thermo-Fluid Dynamics (UIT).

09 December 2021

Hans Meeussen (NRG) has been appointed as part-time associate professor at the Faculty of Civil Engineering and Geosciences of the TU Delft.

26 November 2021

Effective 1 February 2022, Peter Dijk has accepted the position of programme director PALLAS

18 November 2019

Radiopharmaceuticals are vitally important. That’s why NRG|PALLAS, together with partners like AVL, are working on the development of new radiopharmaceuticals in our FIELD-LAB. With this development, we are reinforcing NRG|PALLAS’ leading position in the field of medical isotopes worldwide. We’ve now succeeded in developing a new, efficient and high quality production process for lutetium-177. In order to meet the increasing demand for this kind of radiopharmaceuticals in the future, we will embark on the construction of an isotope production facility (the Nuclear Health Center) next year, followed by the construction of the PALLAS reactor to replace the High Flux Reactor in Petten.

09 October 2019

Ultra Safe Nuclear Corporation (USNC) announces that it has begun working with the Nuclear Research & Consultancy Group (NRG) from the Netherlands. NRG will implement a program to analyze performance and safety attributes of the company’s proprietary Fully Ceramic Microencapsulated (FCMTM) fuel designed for use in its Micro Modular ReactorTM (MMRTM).

More than 2200 companies worldwide rely on NRG services

Test Title

Test